Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Open-market buys, last 90 days
$40,000
in 1 filing
Open-market sales, last 90 days
$247,777
in 3 filings, $248K under 10b5-1 plans

Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kerr Douglas −$116K Chief Medical Officer sold 3% of stake
  2. Cox John −$107K CEO & President sold 2% of stake
  3. Posner Brian S +$40K Director 1 filing
  4. Friedl-Naderer Johanna −$25K Chief Commercial Officer sold <1% of stake

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-14 HIGH SUSANNA GATTI Chief Operating Officer Returned to the company −802 $4.95 $4K 72,201
2022-06-14 Farwell Wildon Chief Medical Officer Returned to the company −668 $4.95 $3K 65,382
2022-06-14 Brumm Joshua T See Remarks Returned to the company −3,540 $4.95 $18K 206,784
2022-06-14 Beskrovnaya Oxana Chief Scientific Officer Returned to the company −726 $4.95 $4K 52,950
2022-06-03 Rhodes Jason P Director Grant or award · Stock Option (right to buy) +19,596 19,596
2022-06-03 Stehman-Breen Catherine Director Grant or award · Stock Option (right to buy) +19,596 19,596
2022-06-03 Lubner David Charles Director Grant or award · Stock Option (right to buy) +19,596 19,596
2022-06-03 Klein Lawrence Otto Director Grant or award · Stock Option (right to buy) +19,596 19,596
2022-06-03 Kersten Dirk Director Grant or award · Stock Option (right to buy) +19,596 19,596
2022-06-03 HURWITZ EDWARD Director Grant or award · Stock Option (right to buy) +19,596 19,596
2022-03-11 Scalzo Richard William See Remarks Sale −308 $8.73 $3K 26,994
2022-03-11 McNeill Jonathan See Remarks Sale −481 $8.73 $4K 60,466
2022-03-11 HIGH SUSANNA GATTI Chief Operating Officer Sale −765 $8.73 $7K 73,003
2022-03-11 Farwell Wildon Chief Medical Officer Sale −640 $8.73 $6K 66,050
2022-03-11 Brumm Joshua T See Remarks Sale −3,384 $8.73 $30K 210,324
2022-03-11 Beskrovnaya Oxana Chief Scientific Officer Sale −693 $8.73 $6K 53,676
2022-03-02 Incerti Carlo Director Grant or award · Stock Option (right to buy) +39,193 39,193
2022-03-02 Farwell Wildon Chief Medical Officer Sale −5,617 $8.56 $48K 66,690
2021-12-10 Scalzo Richard William See Remarks Grant or award +16,696 27,302
2021-12-10 Scalzo Richard William See Remarks Grant or award · Stock Option (right to buy) +25,044 25,044

Page 35 of 36 · 718 trades